Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinic acetylcholine receptor alpha4beta2 (α4β2 nAChR) is a heteropentameric ligand-gated ion channel that mediates fast chemical neurotransmission in the brain. As the most abundant nicotinic subtype in the brain, it plays crucial roles in cognitive function, learning, and various neurological processes. The receptor exists in two stoichiometries with different sensitivities to nicotine and calcium permeability. It is the primary target for nicotine's addictive properties and is implicated in several neurological disorders including Parkinson's disease, Alzheimer's disease, and schizophrenia. The receptor's structure has been determined by X-ray crystallography, revealing insights into its complex architecture and function. Pharmacologically, it can be targeted by various agonists, antagonists, and positive allosteric modulators, making it an important therapeutic target for neurological and psychiatric conditions. Recent research has focused on developing subtype-selective compounds that can modulate α4β2 nAChR function with minimal side effects.
Agonism - direct activation of the receptor leading to cation influx; Positive allosteric modulation - enhancing the effect of endogenous agonists; Antagonism - blocking receptor activation
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic acetylcholine receptor alpha4beta2 (α4β2 nAChR).